Palestine · Delayed Price · Currency is JOD · Price in USD Jerusalem Pharmaceuticals Statistics
Total Valuation
PEX:JPH has a market cap or net worth of JOD 52.94 million. The enterprise value is 44.13 million.
| Market Cap | 52.94M |
| Enterprise Value | 44.13M |
Important Dates
The last earnings date was Sunday, August 10, 2025.
| Earnings Date | Aug 10, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
PEX:JPH has 18.00 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 18.00M |
| Shares Outstanding | 18.00M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 42.26% |
| Owned by Institutions (%) | 5.95% |
| Float | 6.90M |
Valuation Ratios
The trailing PE ratio is 9.66.
| PE Ratio | 9.66 |
| Forward PE | n/a |
| PS Ratio | 1.69 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | 8.57 |
| P/OCF Ratio | 6.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.55, with an EV/FCF ratio of 7.14.
| EV / Earnings | 8.05 |
| EV / Sales | 1.41 |
| EV / EBITDA | 5.55 |
| EV / EBIT | 6.45 |
| EV / FCF | 7.14 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.40 |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.78% and return on invested capital (ROIC) is 8.21%.
| Return on Equity (ROE) | 10.78% |
| Return on Assets (ROA) | 6.48% |
| Return on Invested Capital (ROIC) | 8.21% |
| Return on Capital Employed (ROCE) | 11.34% |
| Revenue Per Employee | 59,021 |
| Profits Per Employee | 10,324 |
| Employee Count | 531 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, PEX:JPH has paid 1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | 20.47% |
Stock Price Statistics
The stock price has increased by +14.44% in the last 52 weeks. The beta is 0.11, so PEX:JPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +14.44% |
| 50-Day Moving Average | 3.81 |
| 200-Day Moving Average | 3.73 |
| Relative Strength Index (RSI) | 68.38 |
| Average Volume (20 Days) | 3,724 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PEX:JPH had revenue of JOD 31.34 million and earned 5.48 million in profits. Earnings per share was 0.30.
| Revenue | 31.34M |
| Gross Profit | 16.66M |
| Operating Income | 6.84M |
| Pretax Income | 6.91M |
| Net Income | 5.48M |
| EBITDA | 7.76M |
| EBIT | 6.84M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 10.29 million in cash and 717,591 in debt, giving a net cash position of 9.57 million or 0.53 per share.
| Cash & Cash Equivalents | 10.29M |
| Total Debt | 717,591 |
| Net Cash | 9.57M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | 55.72M |
| Book Value Per Share | 3.05 |
| Working Capital | 28.97M |
Cash Flow
In the last 12 months, operating cash flow was 7.70 million and capital expenditures -1.51 million, giving a free cash flow of 6.18 million.
| Operating Cash Flow | 7.70M |
| Capital Expenditures | -1.51M |
| Free Cash Flow | 6.18M |
| FCF Per Share | 0.34 |
Margins
Gross margin is 53.16%, with operating and profit margins of 21.83% and 17.49%.
| Gross Margin | 53.16% |
| Operating Margin | 21.83% |
| Pretax Margin | 22.06% |
| Profit Margin | 17.49% |
| EBITDA Margin | 24.75% |
| EBIT Margin | 21.83% |
| FCF Margin | 19.72% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -19.95% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.62% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 10.35% |
| FCF Yield | 11.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2013. It was a forward split with a ratio of 1.4216864044.
| Last Split Date | Aug 1, 2013 |
| Split Type | Forward |
| Split Ratio | 1.4216864044 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |